UK markets open in 4 hours 19 minutes
NIKKEI 225
38,245.36 +16.25 (+0.04%) HANG SENG
18,991.86 +28.18 (+0.15%) CRUDE OIL
77.99 -0.27 (-0.35%) GOLD FUTURES
2,364.50 -10.50 (-0.44%) DOW
39,512.84 +837.14 (+2.16%) Bitcoin GBP
48,821.38 +196.67 (+0.40%)
BEAM Oct 2024 24.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:51PM EDT. Market open.
| Previous close | 4.2800 |
| Open | 4.2800 |
| Bid | 2.7000 |
| Ask | 3.7000 |
| Strike | 24.00 |
| Expiry date | 2024-10-18 |
| Day's range | 4.2800 - 4.2800 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Simply Wall St.Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders are probably feeling a little disappointed, since its shares fell...
ZacksBeam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
Beam Therapeutics (BEAM) reports mixed first-quarter results. The company remains focused on pipeline development.
GlobeNewswireBeam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to participate in a fireside chat during the RBC Capital Markets 2024 Global Healthcare Conference on Wednesday, May 15, 2024, at 1:35 p.m. ET in New York City. A live webcast will be available in the investor section of the company's website at www.bea
© 2024 Yahoo. All rights reserved.